Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2006 2
2007 1
2009 1
2010 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
A pharmacogenetics study of the human glucuronosyltransferase UGT1A4.
Benoit-Biancamano MO, Adam JP, Bernard O, Court MH, Leblanc MH, Caron P, Guillemette C. Benoit-Biancamano MO, et al. Among authors: bernard o, guillemette c. Pharmacogenet Genomics. 2009 Dec;19(12):945-54. doi: 10.1097/FPC.0b013e3283331637. Pharmacogenet Genomics. 2009. PMID: 19890225 Free PMC article.
The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants.
Bernard O, Guillemette C. Bernard O, et al. Among authors: guillemette c. Drug Metab Dispos. 2004 Aug;32(8):775-8. doi: 10.1124/dmd.32.8.775. Drug Metab Dispos. 2004. PMID: 15258099
Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer.
Gagnon JF, Bernard O, Villeneuve L, Têtu B, Guillemette C. Gagnon JF, et al. Among authors: bernard o, guillemette c. Clin Cancer Res. 2006 Mar 15;12(6):1850-8. doi: 10.1158/1078-0432.CCR-05-2130. Clin Cancer Res. 2006. PMID: 16551870 Free article.
Pharmacogenetic impact of UDP-glucuronosyltransferase metabolic pathway and multidrug resistance-associated protein 2 transport pathway on mycophenolic acid in thoracic transplant recipients: an exploratory study.
Ting LS, Benoit-Biancamano MO, Bernard O, Riggs KW, Guillemette C, Ensom MH. Ting LS, et al. Among authors: bernard o, guillemette c. Pharmacotherapy. 2010 Nov;30(11):1097-108. doi: 10.1592/phco.30.11.1097. Pharmacotherapy. 2010. PMID: 20973683
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.
Lépine J, Bernard O, Plante M, Têtu B, Pelletier G, Labrie F, Bélanger A, Guillemette C. Lépine J, et al. Among authors: bernard o, guillemette c. J Clin Endocrinol Metab. 2004 Oct;89(10):5222-32. doi: 10.1210/jc.2004-0331. J Clin Endocrinol Metab. 2004. PMID: 15472229
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.
Girard H, Court MH, Bernard O, Fortier LC, Villeneuve L, Hao Q, Greenblatt DJ, von Moltke LL, Perussed L, Guillemette C. Girard H, et al. Among authors: bernard o, guillemette c. Pharmacogenetics. 2004 Aug;14(8):501-15. doi: 10.1097/01.fpc.0000114754.08559.27. Pharmacogenetics. 2004. PMID: 15284532
The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
Lévesque E, Delage R, Benoit-Biancamano MO, Caron P, Bernard O, Couture F, Guillemette C. Lévesque E, et al. Among authors: bernard o, guillemette c. Clin Pharmacol Ther. 2007 Mar;81(3):392-400. doi: 10.1038/sj.clpt.6100073. Clin Pharmacol Ther. 2007. PMID: 17339869
Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.
Bernard O, Tojcic J, Journault K, Perusse L, Guillemette C. Bernard O, et al. Among authors: guillemette c. Drug Metab Dispos. 2006 Sep;34(9):1539-45. doi: 10.1124/dmd.106.010553. Epub 2006 Jun 21. Drug Metab Dispos. 2006. PMID: 16790554
Feedback